A randomized, double‐blind phase I/IIa study of intranasal glutathione in Parkinson's disease

E-ISSN： 1531-8257|30|12|1696-1701

ISSN： 0885-3185

Source： MOVEMENT DISORDERS, Vol.30, Iss.12, 2015-10, pp. : 1696-1701

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Zonisamide improves wearing‐off in Parkinson's disease: A randomized, double‐blind study

MOVEMENT DISORDERS, Vol. 30, Iss. 10, 2015-09 ,pp. : 1343-1350

John Wiley & Sons Inc

Access to resources Recommend Favorite

The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double‐blind, placebo‐controlled, multicenter study

MOVEMENT DISORDERS, Vol. 30, Iss. 7, 2015-06 ,pp. : 1009-1009

John Wiley & Sons Inc

Access to resources Recommend Favorite

Short pulse width in subthalamic stimulation in Parkinson's disease: a randomized, double‐blind study

MOVEMENT DISORDERS, Vol. 33, Iss. 1, 2018-01 ,pp. : 169-173

John Wiley & Sons Inc

Access to resources Recommend Favorite

A randomized, double‐blind, placebo‐controlled trial of camicinal in Parkinson's disease

MOVEMENT DISORDERS, Vol. 33, Iss. 2, 2018-02 ,pp. : 329-332

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ropinirole 24-hour prolonged release and ropinirole immediate release in early Parkinson's disease: a randomized, double-blind, non-inferiority crossover study

By Stocchi Fabrizio Hersh Bonnie P. Scott Burton L. Nausieda Paul A. Giorgi Luigi

Current Medical Research and Opinion, Vol. 24, Iss. 10, 2008-10 ,pp. : 2883-2895

Informa Healthcare

Access to resources Recommend Favorite